People in remission from immune-mediated thrombotic thrombocytopenic purpura (iTTP) may have a higher risk of certain major cardiovascular events, particularly stroke, according to a study out of Italy. Compared with the overall Italian population, people who had reached clinical remission after recovering from an iTTP attack had higher-than-expected rates…